1,410 results on '"Bipolar disorder -- Care and treatment"'
Search Results
2. Study Data from Deakin University Update Understanding of Bipolar Disorders (New Advances In the Pharmacology and Toxicology of Lithium: a Neurobiologically Oriented Overview)
3. Mental HEALTH DISORDERS HIGH AMONG COSMETIC PATIENTS
4. Risperidone (generic) Risperdal (brand)
5. Aripiprazole (generic) Abilify (brand)
6. MANAGING BIPOLAR DISORDER: Personalization and Education Are Key
7. Becoming Comfortable With Discomfort: Polypharmacy for Patients With Substance Use Disorders
8. University of Pisa Researcher Focuses on Bipolar Disorders (Pseudodementia in Patients with Unipolar and Bipolar Disorders: A Case Series and Literature Review)
9. University Hospitals Cleveland Medical Center Researcher Reports Recent Findings in Bipolar Disorders (Possible Role of Correlation Coefficients and Network Analysis of Multiple Intracellular Proteins in Blood Cells of Patients with Bipolar ...)
10. Asenapine (generic): Saphris (brand)
11. Autobahn Therapeutics Announces Initiation of its AMPLIFY Phase 2 Trial of ABX-002 as an Adjunctive Treatment for Major Depressive Disorder
12. NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Featured on Psychiatrist.com
13. Thinking Beyond the Guidelines: Evidence-Based Novel Therapies for Bipolar Depression
14. Vancouver mother wants to know: What has happened to my mentally ill son?
15. Risperidone long-acting injectable (generic): Risperdal Consta (BRAND)
16. Desvenlafaxine extended release (generic): Pristiq (BRAND)
17. Data from Warsaw University of Life Sciences Advance Knowledge in Bipolar Disorders (Pro/antioxidant status and selenium, zinc and arsenic concentration in patients with bipolar disorder treated with lithium and valproic acid)
18. Data from Santa Casa de Sao Paulo School of Medical Sciences Broaden Understanding of Bipolar Disorders (The anti-anhedonic effects of ketamine in the treatment of resistant unipolar and bipolar depression: A systematic review and meta-analysis ...)
19. University of New South Wales Researcher Describes Research in Bipolar Disorders (Factors associated with electroconvulsive therapy treatment for adults with serious psychiatric conditions in Australia)
20. Investigators at New York Medical College Describe Findings in Bipolar Disorders (Effects of Cariprazine On Reducing Symptoms of Irritability, Hostility, and Agitation In Patients With Manic or Mixed Episodes of Bipolar I Disorder)
21. Autobahn Therapeutics Completes Oversubscribed $100 Million Series C Financing to Advance Pipeline of Novel Therapeutics for Depression and Other CNS Disorders
22. AANA Issues Updated Practice Considerations for Ketamine Therapy for Psychiatric Disorders and Chronic Pain Management
23. Alzamend Neuro Announces Initial Closing of Private Placement
24. Neumora Therapeutics Announces Initiation of Phase 2 Study of Navacaprant in Bipolar Depression
25. Alzamend Neuro Announces Agreement for Registered Direct Offering and Concurrent Private Placement for an Aggregate of up to $25 Million
26. Study Results from Postgraduate Institute of Medical Education and Research Update Understanding of Drug Abuse [Prevalence and Association of Comorbid Substance Dependence On the Course and Outcome of Bipolar Disorder: Findings From the Bipolar ...]
27. Limited evidence of autocorrelation signaling upcoming affective episodes: a 12-month e-diary study in patients with bipolar disorder (Updated June 20, 2024)
28. Evidence for mood instability in patients with bipolar disorder: Applying multilevel hidden Markov modelling to intensive longitudinal ecological momentary assessment data (Updated June 20, 2024)
29. Data from University of Southern California (USC) Advance Knowledge in Bipolar Disorders [Lift (A Lithium Fiber-based Test): an At-home Companion Diagnostics for a Safer Lithium Therapy In Bipolar Disorder]
30. Reports from Southern Medical University Advance Knowledge in Personalized Medicine (Retrospective Analysis of Steady-State Sodium Valproate Plasma Concentrations in Chinese Patients With Bipolar Disorder: Impact of Demographic and Clinical ...)
31. Bipolar disorder: Raising awareness
32. Talkiatry Celebrates One Million Patient Visits
33. NIMHANS & NCBS get Rs. 100 crore grant from Philanthropies Foundation to explore novel therapies for mental disorders
34. University of Sao Paulo Medical School Researchers Provide New Study Findings on Bipolar Disorders (Structured physical exercise for bipolar depression: an open-label, proof-of concept study)
35. Adjunctive dextromethorphan/quinidine promising in pilot study for depression
36. University of New South Wales Researcher Publishes New Studies and Findings in the Area of Bipolar Disorders (Phase-based concerns of caregivers for individuals with a bipolar disorder)
37. Studies from Bioaraba Health Research Institute Have Provided New Data on Personalized Medicine (Lithium levels and lifestyle in patients with bipolar disorder: a new tool for self-management)
38. Rohini Nilekani philanthropies grants Rs. 100 cr to NIMHANS-NCBS to spur research to treat 5 major mental health disorders
39. Intra-Cellular reports positive results from Study 403 evaluating lumateperone as monotherapy in patients with MDD with mixed features and bipolar depression with mixed features
40. Olanzapine (generic)
41. NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Completion of Enrollment of its Phase 2b|3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression
42. Alkermes Announces Topline Results From Long-Term, Open-Label Safety and Durability of Treatment Effect Study of LYBALVI (olanzapine and samidorphan)
43. Differential Serum Levels of CACNA1C, Circadian Rhythm and Stress Response Molecules in Subjects with Bipolar Disorder: Associations with Genetic and Clinical Factors
44. Electroconvulsive therapy ECT shown to reduce severity of certain mental illnesses
45. Findings from Ardakan University in Borderline Personality Disorder Reported (The comparison of hot and cold executive functions in patients with bipolar II disorder, borderline personality disorder, and healthy individuals)
46. Reports Summarize Bipolar Disorders Findings from Massachusetts General Hospital (Stimulant Treatment and Potential Adverse Outcomes In Pediatric Populations With Bipolar Disorder: a Systematic Review of the Literature)
47. New Mental Health Diseases and Conditions Study Findings Have Been Reported by Researchers at University of Chicago Medicine (Prescription of Long-acting Injectable Antipsychotic Medications Among Outpatient Mental Health Care Service Providers)
48. Dr. Bal Nandra & Ketamine Centers of Chicago discusses Ketamine for TRD
49. AANA and APNA Issue Joint Statement on Ketamine Infusion Therapy for Psychiatric Disorders
50. NRx Pharma to begin phase 3 trial of NRX-101 to treat bipolar depression with acute suicidality
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.